To explain this peculiarity, it has been hypothesized that RPS26-deficient 40S subunits found in RPS26-mutated DBA patients could selectively translate subsets of mRNAs with a protective function against cancer development (Lipton et al., 2022). The gene discussed is RPS26; the disease is cancer.